Global and China Prenatal and Newborn Genetic Testing Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 21-Sep-2020
No. of pages: 129
Inquire Before Buying

Global Prenatal and Newborn Genetic Testing Scope and Market Size

Prenatal and Newborn Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prenatal and Newborn Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Array-Comparative Genetic Hybridization (aCGH)

- Fluorescence In-Situ Hybridization (FISH)

- Polymerase Chain Reaction (PCR)

Market segment by Application, split into

- Hospitals

- Diagnostic Organization

- Other

Based on regional and country-level analysis, the Prenatal and Newborn Genetic Testing market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Prenatal and Newborn Genetic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Roche Diagnostic

- Elitech Group

- Myriad Genetics

- Biocartis

- IntegraGen

- Perkin Elmer

- WaferGen Biosystem

- Interpace Diagnostics

- Quest Diagnostic

- Bio-Rad

- AutoGenomics

- Abbott

- Cepheid

- EKF Diagnostics

- Natera

- Agilent Technologies

- Illumina

- Ariosa Diagnostics

- Sequenom

Global and China Prenatal and Newborn Genetic Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Array-Comparative Genetic Hybridization (aCGH)
1.2.3 Fluorescence In-Situ Hybridization (FISH)
1.2.4 Polymerase Chain Reaction (PCR)
1.3 Market by Application
1.3.1 Global Prenatal and Newborn Genetic Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Diagnostic Organization
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prenatal and Newborn Genetic Testing Market Perspective (2015-2026)
2.2 Global Prenatal and Newborn Genetic Testing Growth Trends by Regions
2.2.1 Prenatal and Newborn Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prenatal and Newborn Genetic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Prenatal and Newborn Genetic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal and Newborn Genetic Testing Players by Market Size
3.1.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue (2015-2020)
3.1.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Players (2015-2020)
3.2 Global Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prenatal and Newborn Genetic Testing Revenue
3.4 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio
3.4.1 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal and Newborn Genetic Testing Revenue in 2019
3.5 Key Players Prenatal and Newborn Genetic Testing Area Served
3.6 Key Players Prenatal and Newborn Genetic Testing Product Solution and Service
3.7 Date of Enter into Prenatal and Newborn Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal and Newborn Genetic Testing Breakdown Data by Type (2015-2026)
4.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Type (2015-2020)
4.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2021-2026)
5 Prenatal and Newborn Genetic Testing Breakdown Data by Application (2015-2026)
5.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Application (2015-2020)
5.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prenatal and Newborn Genetic Testing Market Size (2015-2026)
6.2 North America Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
6.3 North America Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
6.4 North America Prenatal and Newborn Genetic Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Prenatal and Newborn Genetic Testing Market Size (2015-2026)
7.2 Europe Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
7.4 Europe Prenatal and Newborn Genetic Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Prenatal and Newborn Genetic Testing Market Size (2015-2026)
8.2 China Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
8.3 China Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
8.4 China Prenatal and Newborn Genetic Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Prenatal and Newborn Genetic Testing Market Size (2015-2026)
9.2 Japan Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
9.3 Japan Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
9.4 Japan Prenatal and Newborn Genetic Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Prenatal and Newborn Genetic Testing Market Size (2015-2026)
10.2 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Roche Diagnostic
11.1.1 Roche Diagnostic Company Details
11.1.2 Roche Diagnostic Business Overview
11.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Introduction
11.1.4 Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020))
11.1.5 Roche Diagnostic Recent Development
11.2 Elitech Group
11.2.1 Elitech Group Company Details
11.2.2 Elitech Group Business Overview
11.2.3 Elitech Group Prenatal and Newborn Genetic Testing Introduction
11.2.4 Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.2.5 Elitech Group Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Details
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Introduction
11.3.4 Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.3.5 Myriad Genetics Recent Development
11.4 Biocartis
11.4.1 Biocartis Company Details
11.4.2 Biocartis Business Overview
11.4.3 Biocartis Prenatal and Newborn Genetic Testing Introduction
11.4.4 Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.4.5 Biocartis Recent Development
11.5 IntegraGen
11.5.1 IntegraGen Company Details
11.5.2 IntegraGen Business Overview
11.5.3 IntegraGen Prenatal and Newborn Genetic Testing Introduction
11.5.4 IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.5.5 IntegraGen Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Details
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Introduction
11.6.4 Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.6.5 Perkin Elmer Recent Development
11.7 WaferGen Biosystem
11.7.1 WaferGen Biosystem Company Details
11.7.2 WaferGen Biosystem Business Overview
11.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Introduction
11.7.4 WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.7.5 WaferGen Biosystem Recent Development
11.8 Interpace Diagnostics
11.8.1 Interpace Diagnostics Company Details
11.8.2 Interpace Diagnostics Business Overview
11.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.8.4 Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.8.5 Interpace Diagnostics Recent Development
11.9 Quest Diagnostic
11.9.1 Quest Diagnostic Company Details
11.9.2 Quest Diagnostic Business Overview
11.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Introduction
11.9.4 Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.9.5 Quest Diagnostic Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Details
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Introduction
11.10.4 Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
11.10.5 Bio-Rad Recent Development
11.11 AutoGenomics
10.11.1 AutoGenomics Company Details
10.11.2 AutoGenomics Business Overview
10.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Introduction
10.11.4 AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.11.5 AutoGenomics Recent Development
11.12 Abbott
10.12.1 Abbott Company Details
10.12.2 Abbott Business Overview
10.12.3 Abbott Prenatal and Newborn Genetic Testing Introduction
10.12.4 Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.12.5 Abbott Recent Development
11.13 Cepheid
10.13.1 Cepheid Company Details
10.13.2 Cepheid Business Overview
10.13.3 Cepheid Prenatal and Newborn Genetic Testing Introduction
10.13.4 Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.13.5 Cepheid Recent Development
11.14 EKF Diagnostics
10.14.1 EKF Diagnostics Company Details
10.14.2 EKF Diagnostics Business Overview
10.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Introduction
10.14.4 EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.14.5 EKF Diagnostics Recent Development
11.15 Natera
10.15.1 Natera Company Details
10.15.2 Natera Business Overview
10.15.3 Natera Prenatal and Newborn Genetic Testing Introduction
10.15.4 Natera Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.15.5 Natera Recent Development
11.16 Agilent Technologies
10.16.1 Agilent Technologies Company Details
10.16.2 Agilent Technologies Business Overview
10.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Introduction
10.16.4 Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.16.5 Agilent Technologies Recent Development
11.17 Illumina
10.17.1 Illumina Company Details
10.17.2 Illumina Business Overview
10.17.3 Illumina Prenatal and Newborn Genetic Testing Introduction
10.17.4 Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.17.5 Illumina Recent Development
11.18 Ariosa Diagnostics
10.18.1 Ariosa Diagnostics Company Details
10.18.2 Ariosa Diagnostics Business Overview
10.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Introduction
10.18.4 Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.18.5 Ariosa Diagnostics Recent Development
11.19 Sequenom
10.19.1 Sequenom Company Details
10.19.2 Sequenom Business Overview
10.19.3 Sequenom Prenatal and Newborn Genetic Testing Introduction
10.19.4 Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
10.19.5 Sequenom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Array-Comparative Genetic Hybridization (aCGH)
Table 4. Key Players of Fluorescence In-Situ Hybridization (FISH)
Table 5. Key Players of Polymerase Chain Reaction (PCR)
Table 6. Global Prenatal and Newborn Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Prenatal and Newborn Genetic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Prenatal and Newborn Genetic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Prenatal and Newborn Genetic Testing Market Share by Regions (2015-2020)
Table 10. Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Prenatal and Newborn Genetic Testing Market Share by Regions (2021-2026)
Table 12. Prenatal and Newborn Genetic Testing Market Market Trends
Table 13. Prenatal and Newborn Genetic Testing Market Drivers
Table 14. Prenatal and Newborn Genetic Testing Market Challenges
Table 15. Prenatal and Newborn Genetic Testing Market Restraints
Table 16. Global Prenatal and Newborn Genetic Testing Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Prenatal and Newborn Genetic Testing Market Share by Players (2015-2020)
Table 18. Global Top Prenatal and Newborn Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2019)
Table 19. Global Prenatal and Newborn Genetic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prenatal and Newborn Genetic Testing Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Prenatal and Newborn Genetic Testing Market Size Share by Type (2015-2020)
Table 25. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type (2021-2026)
Table 26. Global Prenatal and Newborn Genetic Testing Market Size Share by Application (2015-2020)
Table 27. Global Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Prenatal and Newborn Genetic Testing Market Size Share by Application (2021-2026)
Table 29. North America Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Prenatal and Newborn Genetic Testing Market Share by Type (2015-2020)
Table 31. North America Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Prenatal and Newborn Genetic Testing Market Share by Application (2015-2020)
Table 33. North America Prenatal and Newborn Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Prenatal and Newborn Genetic Testing Market Share by Country (2015-2020)
Table 35. Europe Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Prenatal and Newborn Genetic Testing Market Share by Type (2015-2020)
Table 37. Europe Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Prenatal and Newborn Genetic Testing Market Share by Application (2015-2020)
Table 39. Europe Prenatal and Newborn Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Prenatal and Newborn Genetic Testing Market Share by Country (2015-2020)
Table 41. China Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 42. China Prenatal and Newborn Genetic Testing Market Share by Type (2015-2020)
Table 43. China Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 44. China Prenatal and Newborn Genetic Testing Market Share by Application (2015-2020)
Table 45. China Prenatal and Newborn Genetic Testing Market Size by Region (US$ Million) (2015-2020)
Table 46. China Prenatal and Newborn Genetic Testing Market Share by Region (2015-2020)
Table 47. Japan Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Prenatal and Newborn Genetic Testing Market Share by Type (2015-2020)
Table 49. Japan Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Prenatal and Newborn Genetic Testing Market Share by Application (2015-2020)
Table 51. Japan Prenatal and Newborn Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Prenatal and Newborn Genetic Testing Market Share by Country (2015-2020)
Table 53. Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Prenatal and Newborn Genetic Testing Market Share by Type (2015-2020)
Table 55. Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Prenatal and Newborn Genetic Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Prenatal and Newborn Genetic Testing Market Share by Country (2015-2020)
Table 59. Roche Diagnostic Company Details
Table 60. Roche Diagnostic Business Overview
Table 61. Roche Diagnostic Product
Table 62. Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 63. Roche Diagnostic Recent Development
Table 64. Elitech Group Company Details
Table 65. Elitech Group Business Overview
Table 66. Elitech Group Product
Table 67. Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 68. Elitech Group Recent Development
Table 69. Myriad Genetics Company Details
Table 70. Myriad Genetics Business Overview
Table 71. Myriad Genetics Product
Table 72. Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 73. Myriad Genetics Recent Development
Table 74. Biocartis Company Details
Table 75. Biocartis Business Overview
Table 76. Biocartis Product
Table 77. Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 78. Biocartis Recent Development
Table 79. IntegraGen Company Details
Table 80. IntegraGen Business Overview
Table 81. IntegraGen Product
Table 82. IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 83. IntegraGen Recent Development
Table 84. Perkin Elmer Company Details
Table 85. Perkin Elmer Business Overview
Table 86. Perkin Elmer Product
Table 87. Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 88. Perkin Elmer Recent Development
Table 89. WaferGen Biosystem Company Details
Table 90. WaferGen Biosystem Business Overview
Table 91. WaferGen Biosystem Product
Table 92. WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 93. WaferGen Biosystem Recent Development
Table 94. Interpace Diagnostics Business Overview
Table 95. Interpace Diagnostics Product
Table 96. Interpace Diagnostics Company Details
Table 97. Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 98. Interpace Diagnostics Recent Development
Table 99. Quest Diagnostic Company Details
Table 100. Quest Diagnostic Business Overview
Table 101. Quest Diagnostic Product
Table 102. Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 103. Quest Diagnostic Recent Development
Table 104. Bio-Rad Company Details
Table 105. Bio-Rad Business Overview
Table 106. Bio-Rad Product
Table 107. Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 108. Bio-Rad Recent Development
Table 109. AutoGenomics Company Details
Table 110. AutoGenomics Business Overview
Table 111. AutoGenomics Product
Table 112. AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 113. AutoGenomics Recent Development
Table 114. Abbott Company Details
Table 115. Abbott Business Overview
Table 116. Abbott Product
Table 117. Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 118. Abbott Recent Development
Table 119. Cepheid Company Details
Table 120. Cepheid Business Overview
Table 121. Cepheid Product
Table 122. Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 123. Cepheid Recent Development
Table 124. EKF Diagnostics Company Details
Table 125. EKF Diagnostics Business Overview
Table 126. EKF Diagnostics Product
Table 127. EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 128. EKF Diagnostics Recent Development
Table 129. Natera Company Details
Table 130. Natera Business Overview
Table 131. Natera Product
Table 132. Natera Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 133. Natera Recent Development
Table 134. Agilent Technologies Company Details
Table 135. Agilent Technologies Business Overview
Table 136. Agilent Technologies Product
Table 137. Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 138. Agilent Technologies Recent Development
Table 139. Illumina Company Details
Table 140. Illumina Business Overview
Table 141. Illumina Product
Table 142. Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 143. Illumina Recent Development
Table 144. Ariosa Diagnostics Company Details
Table 145. Ariosa Diagnostics Business Overview
Table 146. Ariosa Diagnostics Product
Table 147. Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 148. Ariosa Diagnostics Recent Development
Table 149. Sequenom Company Details
Table 150. Sequenom Business Overview
Table 151. Sequenom Product
Table 152. Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020) (US$ Million)
Table 153. Sequenom Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prenatal and Newborn Genetic Testing Market Share by Type: 2020 VS 2026
Figure 2. Array-Comparative Genetic Hybridization (aCGH) Features
Figure 3. Fluorescence In-Situ Hybridization (FISH) Features
Figure 4. Polymerase Chain Reaction (PCR) Features
Figure 5. Global Prenatal and Newborn Genetic Testing Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Organization Case Studies
Figure 8. Other Case Studies
Figure 9. Prenatal and Newborn Genetic Testing Report Years Considered
Figure 10. Global Prenatal and Newborn Genetic Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Prenatal and Newborn Genetic Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Prenatal and Newborn Genetic Testing Market Share by Regions (2021-2026)
Figure 13. Global Prenatal and Newborn Genetic Testing Market Share by Players in 2019
Figure 14. Global Top Prenatal and Newborn Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Prenatal and Newborn Genetic Testing Revenue in 2019
Figure 16. North America Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Prenatal and Newborn Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Roche Diagnostic Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 44. Elitech Group Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 45. Myriad Genetics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 46. Biocartis Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 47. IntegraGen Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 48. Perkin Elmer Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 49. WaferGen Biosystem Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 50. Interpace Diagnostics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 51. Quest Diagnostic Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 52. Bio-Rad Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 53. AutoGenomics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 54. Abbott Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 55. Cepheid Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 56. EKF Diagnostics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 57. Natera Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 58. Agilent Technologies Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 59. Illumina Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 60. Ariosa Diagnostics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 61. Sequenom Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2015-2020)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs